SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (304)9/6/2002 12:42:30 PM
From: scaram(o)uche  Read Replies (2) of 598
 
Explanation of Responses:

(1) As of August 27, 2002, Zurich Cantonalbank acquired from BZ Group Holding
Limited fifty-one percent of the voting stock of Pharma Vision AG, which
directly beneficially owns 11,358,238 shares of Tularik Inc. common stock. The
principal business address of Pharma Vision AG is Spielhof 3, 8750 Glarus,
Switzerland.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News